Monograph
B01AD01 - Streptokinase |
Not porphyrinogenic |
NP |
Rationale
Enzyme. No CYP-interactions.
Chemical description
Fibrinolytic enzyme given as infusion in coronary infarction and recent thrombosis.
Similar drugs
Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia).
Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway).
What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names
are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
United Kingdom
Biofactor Streptokinase · Biofactor Streptokinase 1.5million unit powder for solution for infusion vials · Biofactor Streptokinase 250,000unit powder for solution for infusion vials · Biofactor Streptokinase 750,000unit powder for solution for infusion vials · Streptase · Streptase 1.5million unit powder for solution for infusion vials · Streptase 250,000unit powder for solution for infusion vials · Streptase 750,000unit powder for solution for infusion vials · Streptokinase · Streptokinase 1.5million unit powder for solution for infusion vials · Streptokinase 250,000unit powder for solution for infusion vials · Streptokinase 750,000unit powder for solution for infusion vialsNorway
Streptokinase biofactorPoland
Biostrepta · DISTREPTAZA
© NAPOS 2024